Literature DB >> 8393162

Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations.

K Ookawa1, M Shiseki, R Takahashi, Y Yoshida, M Terada, J Yokota.   

Abstract

Multiple genetic alterations, including inactivation of the RB gene, occur commonly in small-cell lung carcinoma (SCLC). To assess a functional role of RB inactivation in the development of SCLC, an RB expression plasmid was introduced by stable transfection into SCLC cell lines, Lu-135 and N417, in which the RB gene was inactivated. Lu-135 and N417 cells transfected with the wild-type RB gene formed G418-resistant colonies twofold less efficiently than those with a mutated RB gene or with the control vector. Intact exogenous wild-type RB genes were detected only in approximately 20% of G418-resistant clones; three of 14 in Lu-135 and three of 16 in N417, respectively. Transcripts from the transfected RB gene were also detected in two of these three clones from Lu-135 and two of three from N417 but the amount of RB mRNA and protein was less than one fifth of that in normal fibroblast cells WI-38. Furthermore, clones with exogenous wild-type RB expression showed either reduced growth rates in culture or suppressed tumorigenicity in nude mice. These findings suggest that functional correction of the RB gene is sufficient to suppress the growth of SCLC cells, even though several other genetic alterations in the cells remain uncorrected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393162

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

Review 1.  Tumor suppressor genes in molecular medicine.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Clin Investig       Date:  1994-08

2.  Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle.

Authors:  S Miyake; W R Sellers; M Safran; X Li; W Zhao; S R Grossman; J Gan; J A DeCaprio; P D Adams; W G Kaelin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.

Authors:  Francesco Paolo Fiorentino; Elvan Tokgün; Sònia Solé-Sánchez; Sabrina Giampaolo; Onur Tokgün; Toni Jauset; Takashi Kohno; Manuel Perucho; Laura Soucek; Jun Yokota
Journal:  Oncotarget       Date:  2016-05-24

Review 4.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

5.  The cooperative effect of p53 and Rb in local nanotherapy in a rabbit VX2 model of hepatocellular carcinoma.

Authors:  Shengli Dong; Qibin Tang; Miaoyun Long; Jian Guan; Lu Ye; Gaopeng Li
Journal:  Int J Nanomedicine       Date:  2013-10-02

6.  Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival.

Authors:  Matthew G Oser; Raquel Fonseca; Abhishek A Chakraborty; Rachel Brough; Alexander Spektor; Rebecca B Jennings; Abdallah Flaifel; Jesse S Novak; Aditi Gulati; Elizabeth Buss; Scott T Younger; Samuel K McBrayer; Glenn S Cowley; Dennis M Bonal; Quang-De Nguyen; Laura Brulle-Soumare; Paula Taylor; Stefano Cairo; Colm J Ryan; Elizabeth J Pease; Kim Maratea; Jon Travers; David E Root; Sabina Signoretti; David Pellman; Susan Ashton; Christopher J Lord; Simon T Barry; William G Kaelin
Journal:  Cancer Discov       Date:  2018-10-29       Impact factor: 39.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.